Robert L Erwin
Insider
First SEC filing: July 26, 2012 · Latest: July 26, 2012
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 4, 2020 | IBIO | M | 28,268 | $0.93 | $26,289 | 108,108 Direct | +35.41% | Acquired | -99.8% (price as of 2026-10-02) |
| June 4, 2020 | IBIO | S | 28,268 | $1.71 | $48,338 | 108,108 Direct | -20.73% | Disposed | -99.9% (price as of 2026-10-02) |
| June 4, 2020 | IBIO | M | 28,268 | · | · | 108,108 Direct | -20.73% | Disposed | (price as of 2026-10-02) |
| June 2, 2020 | IBIO | M | 96,124 | $0.93 | $89,395 | 136,376 Direct | +238.81% | Acquired | -99.8% (price as of 2026-10-02) |
| June 2, 2020 | IBIO | S | 96,124 | $1.62 | $155,721 | 136,376 Direct | -41.34% | Disposed | -99.9% (price as of 2026-10-02) |
| June 2, 2020 | IBIO | M | 96,124 | · | · | 136,376 Direct | -41.34% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | D | 25,000 | · | · | 232,500 Direct | -9.71% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | A | 18,750 | · | · | 232,500 Direct | +8.77% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | D | 30,000 | · | · | 232,500 Direct | -11.43% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | A | 22,500 | · | · | 232,500 Direct | +10.71% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | D | 30,000 | · | · | 232,500 Direct | -11.43% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | A | 22,500 | · | · | 232,500 Direct | +10.71% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | D | 30,000 | · | · | 232,500 Direct | -11.43% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | A | 22,500 | · | · | 232,500 Direct | +10.71% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | D | 30,000 | · | · | 232,500 Direct | -11.43% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | A | 22,500 | · | · | 232,500 Direct | +10.71% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | D | 60,000 | · | · | 232,500 Direct | -20.51% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | A | 45,000 | · | · | 232,500 Direct | +24.00% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | D | 75,000 | · | · | 232,500 Direct | -24.39% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | A | 56,250 | · | · | 232,500 Direct | +31.91% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | D | 30,000 | · | · | 232,500 Direct | -11.43% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2019 | IBIO | A | 22,500 | · | · | 232,500 Direct | +10.71% | Acquired | (price as of 2026-10-02) |
| May 1, 2017 | IBIO | A | 300,000 | $0.40 | $120,000 | 3,350,000 Direct | +9.84% | Acquired | -99.9% (price as of 2026-10-02) |
| Sept. 4, 2015 | IBIO | A | 750,000 | $1.72 | $1,290,000 | 3,050,000 Direct | +32.61% | Acquired | -100.0% (price as of 2026-10-02) |
| Sept. 5, 2014 | IBIO | A | 600,000 | $1.00 | $600,000 | 2,300,000 Direct | +35.29% | Acquired | -100.0% (price as of 2026-10-02) |
| July 15, 2013 | IBIO | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 24, 2012 | IBIO | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 21, 2011 | IBIO | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 16, 2010 | IBIO | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 10, 2009 | IBIO | A | 250,000 | · | · | 250,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 13, 2009 | IBIO | A | 250,000 | · | · | 250,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 4, 2020 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 28,268 | Disposed |
| June 2, 2020 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 96,124 | Disposed |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $6.60 | Aug. 10, 2019 | 25,000 | Disposed |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 18,750 | Acquired |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $17.30 | Aug. 16, 2019 | 30,000 | Disposed |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 22,500 | Acquired |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $19.60 | Oct. 21, 2021 | 30,000 | Disposed |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 22,500 | Acquired |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $11.00 | July 24, 2022 | 30,000 | Disposed |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 22,500 | Acquired |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $5.00 | July 16, 2023 | 30,000 | Disposed |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 22,500 | Acquired |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $10.00 | Sept. 5, 2024 | 60,000 | Disposed |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 45,000 | Acquired |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $17.20 | Sept. 4, 2025 | 75,000 | Disposed |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 56,250 | Acquired |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $4.00 | May 1, 2027 | 30,000 | Disposed |
| Feb. 20, 2019 | IBIO | Stock Option (right to buy) | Common Stock | $0.93 | Feb. 20, 2024 | 22,500 | Acquired |
| May 1, 2017 | IBIO | Stock Option (right to buy) | Common Stock | $0.40 | May 1, 2027 | 300,000 | Acquired |
| Sept. 4, 2015 | IBIO | Stock Option (right to buy) | Common Stock | $1.72 | Sept. 4, 2025 | 750,000 | Acquired |
| Sept. 5, 2014 | IBIO | Stock Option (right to buy) | Common Stock | $1.00 | Sept. 5, 2024 | 600,000 | Acquired |
| July 15, 2013 | IBIO | Stock Option (right to buy) | Common Stock | $0.52 | July 15, 2023 | 300,000 | Acquired |
| July 24, 2012 | IBIO | Stock Option (right to buy) | Common Stock | $1.10 | July 24, 2022 | 300,000 | Acquired |
| Oct. 21, 2011 | IBIO | Stock Option (right to buy) | Common Stock | $1.96 | Oct. 21, 2021 | 300,000 | Acquired |
| Aug. 16, 2010 | IBIO | Stock Option (right to buy) | Common Stock | $1.73 | Aug. 16, 2020 | 300,000 | Acquired |
| Aug. 10, 2009 | IBIO | Stock Option (right to buy) | Common Stock | $0.66 | Aug. 10, 2019 | 250,000 | Acquired |
| Feb. 13, 2009 | IBIO | Stock Option (right to buy) | Common Stock | $0.20 | Feb. 13, 2019 | 250,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $275,000 | · | · | · | · | · | $16,751 | $291,751 |
| 2018 | · | · | · | · | · | · | · | · |
| 2017 | $230,000 | · | · | $107,085 | · | · | · | $337,085 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.